CoChat

Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials

Open access
Aspinall, Rebecca L, Goodman, Neville W · 1995 · BMJ
Cited by 97

The DOI matches its Crossref record.

Abstract

Objective : To determine how many patients were deprived of treatment by being given placebo as comparator in trials of ondansetron for postoperative nausea and vomiting. Design : Review of published trials of ondansetron during 1991 to July 1994. Setting : Medline search in a university department of anaesthesia. Subjects : 8806 patients who had been included in 18 indexed placebo controlled trials of ondansetron as prophylaxis against or treatment of postoperative nausea and vomiting. Results : Five studies (1236 patients) had been published by July 1992. All were placebo controlled trials. By July 1994, 8806 patients had been included in 18 indexed placebo controlled studies of prophylaxis or treatment. Only 462 patients had been in studies that compared ondansetron with other drugs, and there were no indexed comparative trials of treatment of nausea and vomiting. Roughly 2180 patients had been given placebo as prophylaxis and 440 had been given placebo when already experiencing postoperative nausea or vomiting. Conclusions : Around 2620 patients in the reviewed studies were denied existing drugs, which, though not completely effective or without side effects, do bring some relief from postoperative nausea and vomiting. Drug regulatory bodies should collaborate with drug companies to ensure better comparison of new with established drugs. This would avoid placebos being given to more than the fewest patients necessary to confirm effect and would allow doctors to be informed more quickly about relative efficacies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.311.7009.844

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 37

  1. Claybon, 1994, Single dose intravenous ondansetron for the 24-hour treatment of postoperative nausea and vomiting., Anaesthesia, 49, 24, 10.1111/j.1365-2044.1994.tb03579.x · DOI
  2. Altman DG .Practical statistics for medical research. London: Chapman and Hall,1991: 450–1. · DOI · Paper page
  3. 10.1136/jme.19.4.211 · doi:10.1136/jme.19.4.211
  4. Alon, 1992, Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide., Anesth Analg, 75, 561, 10.1213/00000539-199210000-00017 · DOI
  5. Dupeyron, 1993, The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia., Anaesthesia, 48, 214, 10.1111/j.1365-2044.1993.tb06904.x · DOI
  6. 10.1016/0140-6736(93)90637-V · doi:10.1016/0140-6736(93)90637-v
  7. Isal, 1992, The clinical development of ondansetron for use in the prevention and treatment of postoperative nausea and vomiting., Eur J Anaesthesiol, 9, 33
  8. Joslyn, 1994, Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions., Anaesthesia, 49, 34, 10.1111/j.1365-2044.1994.tb03581.x · DOI
  9. Russell, 1992, 5-HT3 antagonists in postoperative nausea and vomiting., Br J Anaesth, 69, 63, 10.1093/bja/69.supplement_1.63S · DOI
  10. Bero, 1992, The publication of sponsored symposiums in medical journals., N Engl J Med, 327, 1135, 10.1056/NEJM199210153271606 · DOI · Paper page
  11. 10.1001/jama.1994.03520020034009 · DOI · Paper page
  12. 10.1001/jama.1994.03510320052029 · DOI · Paper page
  13. Bohrer, 1994, Ondansetron–Ein neues anasthesierelevantes Antiemetikum? Anaesthesiol Reanim, 19, 11
  14. Rosen, 1994, Foreword: ondansetron–a new concept in antiemetic therapy for popstoperative nausea and vomiting., Anaesthesia, 49, 1, 10.1111/j.1365-2044.1994.tb03574.x · doi:10.1111/j.1365-2044.1994.tb03574.x
  15. Herxheimer, 1990, Promotion by the British pharmaceutical industry, 1983–8: a critical analysis of self regulation., BMJ, 300, 307, 10.1136/bmj.300.6720.307 · doi:10.1136/bmj.300.6720.307
  16. 10.1056/NEJM199408113310611 · DOI · Paper page
  17. Kaufmann, 1994, Prophylactic antiemetic therapy with patient-controlled analgesia: a double-blind, placebo-controlled comparison of droperidol, metoclopramide, and tropisetron., Anesth Analg, 78, 988, 10.1213/00000539-199405000-00027 · DOI
  18. Leeser, 1991, Prevention of postoperative nausea and vomiting using ondansetron, a new, selective, 5-HT3 receptor antagonist., Anesth Analg, 72, 751, 10.1213/00000539-199106000-00005 · DOI
  19. Larijani, 1991, Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo., Anesth Analg, 73, 246, 10.1213/00000539-199109000-00002 · DOI · Paper page
  20. Bodner, 1991, Antiemetic efficacy of ondansetron after outpatient laparoscopy., Anesth Analg, 73, 250, 10.1213/00000539-199109000-00003 · DOI
  21. 10.1093/bja/68.5.466 · DOI
  22. Dershwitz, 1992, Ondansetron is effective in decreasing postoperative nausea and vomiting., Clin Pharmacol Ther, 52, 96, 10.1038/clpt.1992.107 · DOI
  23. Kovac, 1992, Prophylactic intravenous ondansetron in female outpatients undergoing gynaecological surgery: a multicentre dose-comparison study., Eur J Anaesthesiol, 9, 37
  24. Helmers, 1992, Oral ondansetron in the prevention of postoperative nausea and vomiting., Eur J Anaesthesiol, 9, 49
  25. DuPen, 1992, Ondansetron in the treatment of postoperative nausea and vomiting in ambulatory patients: a dose-comparative, stratified, multicentre study., Eur J Anaesthesiol, 9, 55
  26. 10.1016/S0750-7658(05)80754-3 · doi:10.1016/s0750-7658(05)80754-3
  27. 10.1016/0952-8180(93)90084-R · DOI
  28. Sung, 1993, A double-blind, placebo-controlled pilot study examining the effectiveness of intravenous ondansetron in the prevention of postoperative nausea and emesis., J Clin Anesth, 5, 22, 10.1016/0952-8180(93)90083-Q · DOI
  29. Scuderi, 1993, Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT(sub 3) antagonist ondansetron., Anesthesiology, 78, 15, 10.1097/00000542-199301000-00004 · DOI · Paper page
  30. 10.1097/00000542-199308000-00001 · doi:10.1097/00000542-199308000-00001
  31. Helmers, 1993, A single iv dose of ondansetron 8 mg prior to induction of anaesthesia reduces postoperative nausea and vomiting in gynaecological patients., Can J Anaesth, 40, 1155, 10.1007/BF03009605 · doi:10.1007/bf03009605
  32. 10.1093/bja/71.6.845 · DOI
  33. Pearman, 1994, Single dose intravenous ondansetron in the prevention of postoperative nausea and vomiting., Anaesthesia, 49, 11, 10.1111/j.1365-2044.1994.tb03577.x · DOI
  34. Rust, 1994, Single oral dose ondansetron in the prevention of postoperative nausea and emesis., Anaesthesia, 49, 16, 10.1111/j.1365-2044.1994.tb03578.x · DOI
  35. 10.1093/bja/72.2.231 · DOI
  36. Litman, 1994, Ondansetron decreases emesis after tonsillectomy in children., Anesth Analg, 78, 478, 10.1213/00000539-199403000-00010 · DOI
  37. 10.1093/bja/72.5.544 · DOI

Cited by

See all 97

Metadata

Authors
Aspinall, R. L., & Goodman, N. W.
Venue
BMJ
Publisher
BMJ
Published
1995-09-30
Volume
311
Issue
7009
Pages
844-846
ISSN
  • 0007-1447 (ISSN-L)
  • 0959-8138
  • 1468-5833
OpenAlex
W2045755475
Cited by
97
References
0
FWCI
7.08
Type
journal article
Language
en
Open access
green
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. https://app.cochat.ai/papers/10.1136/bmj.311.7009.844
The paper
Aspinall, R. L., & Goodman, N. W. (1995). Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ. https://doi.org/10.1136/bmj.311.7009.844

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.